TP53 mutations are only found in a fraction of human medulloblastomas of the Wnt (16%) and Shh (21%) subtypes, although they correlate with poor survival and treatment failures in Shh-driven medulloblastoma [38, 82, 83]. Here, SHH is linked to medulloblastoma.